SM-1 Combined With Temozolomide in Subjects With Refractory or Recurrent High-Grade Gliomas

NCT07635173 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Glioma
Glioblastomas (GBM)
High Grade Gliomas

Interventions

DRUG: SM-1,TMZ

Sponsor

Shenzhen Zhenxing Medical Technology Co., Ltd